Cancer
Researchers from Jamia Hamdard University have discovered that CD4 T-cells play a crucial role in cancer immunology, and novel drug delivery systems, particularly nanoparticle-based formulations, can enhance antitumor immune responses while minimizing systemic toxicity. The study aimed to explore the immunological significance of CD4 T-cells in cancer and their modulation
Cancer
Researchers from the Mayo Clinic have made a groundbreaking discovery in the field of cancer gene therapy. By leveraging preexisting anti-viral memory responses, they have found a way to focus high-affinity T cell responses into tumors, leading to cancer cures. This innovative approach utilizes oncolytic viruses or chimeric antigen receptors
Cancer
Recent research from Kwara State University has shed light on the challenges and opportunities in cancer immunotherapy, particularly with the use of interleukin-12 (IL-12) based strategies. The study aims to address the translational challenges and clinical implications of IL-12 therapy, which has shown promising therapeutic potential in treating various cancer
Cancer research
Investigators at the University of Padua, Italy have published a new study on cancer gene therapy, highlighting the potential of oncolytic viruses (OVs) to induce cancer cell death while stimulating immune responses. The research, partially funded by the Vrije Universiteit Brussel and the Foundation Against Cancer, demonstrates the effectiveness of
Cancer
Researchers at Tianjin Medical University General Hospital have reported a potential immunotherapeutic target for gastric cancer, revealing a novel role of EBI3 in promoting CD8+ T cell exhaustion and compromising the effectiveness of immunotherapy. The study highlights the correlation between EBI3 expression levels and clinical-pathological features of gastric cancer, including
Cancer research
Researchers from Fudan University have made a significant discovery in cancer gene therapy, shedding light on the potential relationship between lipid metabolic reprogramming and immunotherapy resistance in hepatocellular carcinoma (HCC). The study reveals that transforming acidic coiled-coil-containing protein 3 (TACC3) plays a crucial role in maintaining polyunsaturated fatty acid (PUFA)
Cancer research
Researchers at Tianjin University have made a groundbreaking discovery in the field of cancer immunotherapy. Using a defined co-culture system of tumor-specific CTLs and cognate antigen-expressing tumor cells, the team observed that tryptophan (Trp) level is elevated in the tumor cell-activated CTLs. This finding led to the identification of a
Cancer research
Researchers at the University of Chicago have provided new study findings on the effectiveness of tumor response in non-small cell lung cancer (NSCLC) patients treated with immunotherapy and chemotherapy. The study, which evaluated data from two phase III clinical trials, KEYNOTE-189 and KEYNOTE-407, investigated the association between tumor size changes
Cancer research
Researchers at UT Southwestern Medical Center have discovered that certain features in the blood of cancer patients may indicate a higher risk of experiencing side effects from immunotherapy. The team analyzed blood samples from 162 patients before and after treatment and identified three key features linked to a higher risk
Cancer research
Research highlights the concerning prevalence of non-melanoma skin cancer in renal transplant recipients, particularly in those undergoing long-term immunosuppressive therapy. A recent study outlined the potential benefits of belatacept, a selective co-stimulation blocker, in reducing cancer risk while minimizing immunosuppression. However, the study also emphasized the need for further randomized
Cancer
The phase 2 clinical trial, Combi-TED, has successfully completed the enrollment of 105 HLA-A2 positive patients with non-small cell lung cancer (NSCLC) to evaluate the efficacy of Tedopi, a neoepitope-based therapeutic cancer vaccine, in combination with either nivolumab or docetaxel. This trial is an open-label, randomized, three-arm study assessing the
Cancer
Researchers from First Hospital of China Medical University have made a significant breakthrough in the treatment of gastrointestinal tumors. According to a study published in Frontiers in Medicine, the combination of nanotechnology and natural killer (NK) cell immunotherapy has shown promise in targeting cancer cells while minimizing harm to healthy
